Whalegun
Home

Orbimed Advisors, Director: ARS Pharmaceuticals SPRY Sell · Filed 24/08/23

Trade details

Type
Insider sale
Amount
$5,332,288
Shares · price
394,400 sh · $13.52 a share
Held after
557,977 sh
Stock
ARS Pharmaceuticals SPRY
Person
Orbimed AdvisorsDirector
Trade date
24/08/21
Filed
24/08/23
Days to filing
2 days

Sold 41.4% of holdings

Share of holding sold
41.4%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/07/22~24/09/20

Orbimed Advisors's recent trades

  • Orbimed Advisors

    BuyADARx Pharmaceuticals

    $10M

    Filed 09/30

  • Orbimed Advisors

    BuyADARx Pharmaceuticals

    $5.1M

    Filed 09/30

  • Orbimed Advisors

    BuyADARx Pharmaceuticals

    $1M

    Filed 09/30

  • Orbimed Advisors

    BuyElectra Therapeutics

    $15M

    Filed 09/23

  • Orbimed Advisors

    BuyElectra Therapeutics

    $5M

    Filed 09/23

Orbimed Advisors, Director — sold $5.3M of ARS Pharmaceuticals SPRY · 41.4% of holdings | Whalegun